J&J (JNJ) Plans to Develop Vaccine for New Coronavirusis looking to develop a vaccine for the new coronavirus infection. Its drug Erleada’s label is expanded to include new prostate cancer patient population in Europe.
News story posted on 2020-02-01T01:35:00.0000000Z
J&J (JNJ) Plans to Develop Vaccine for New Coronavirus
